Tscan Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Tscan Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Tscan Therapeutics Inc
Rating: 1.75116675
Author: Trendlyne DVM scores

about

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and ...

1.14 0.02 (1.79%)

57.30% Fall from 52W High

330.0K

XNAS Volume

XNAS 21 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

23.7 / 100

Technically Neutral

46.4 / 100

1Yr Price target upside is 426%

4 analysts

Tscan Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tscan Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and ...

57.30% Fall from 52W High

SWOT Analysis

Tscan Therapeutics Inc Live Price Chart